医疗器械临床试验质量管理规范英文版.docx

上传人:b****8 文档编号:13024539 上传时间:2023-06-10 格式:DOCX 页数:18 大小:26.28KB
下载 相关 举报
医疗器械临床试验质量管理规范英文版.docx_第1页
第1页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第2页
第2页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第3页
第3页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第4页
第4页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第5页
第5页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第6页
第6页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第7页
第7页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第8页
第8页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第9页
第9页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第10页
第10页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第11页
第11页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第12页
第12页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第13页
第13页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第14页
第14页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第15页
第15页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第16页
第16页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第17页
第17页 / 共18页
医疗器械临床试验质量管理规范英文版.docx_第18页
第18页 / 共18页
亲,该文档总共18页,全部预览完了,如果喜欢就下载吧!
下载资源
资源描述

医疗器械临床试验质量管理规范英文版.docx

《医疗器械临床试验质量管理规范英文版.docx》由会员分享,可在线阅读,更多相关《医疗器械临床试验质量管理规范英文版.docx(18页珍藏版)》请在冰点文库上搜索。

医疗器械临床试验质量管理规范英文版.docx

医疗器械临床试验质量管理规范英文版

StateFoodandDrugAdministration

NationalHealthandFamilyPlanningCommission

Numbertwenty-fifth

hasbeenstatefoodandDrugAdministrationintheexecutivemeetingofthe,nationalhealthandFamilyPlanningCommission,directorofthecommitteemeetingexaminedandadopted,isherebypromulgated,sinceJune1,2016implementation.

DirectorBiJingquan

DirectorLiBin

March1,2016

Standardforqualitymanagementofmedicaldeviceclinicaltrials

Chapteroneisthefirstchapter

Thefirstistostrengthenthemanagementofmedicaldeviceclinicaltrials,themaintenanceprocessforclinicaltrialsofmedicaldevicesinrightsandinterests,andtoguaranteethemedicaldeviceclinicaltrialsprocessspecification,realresults,science,reliableandtraceable,accordingtoformulatedthisspecification.

Article2withintheterritoryofthepeople'sRepublicofChinatocarryouttheclinicaltrialofmedicalapparatusandinstruments,shallcomplywiththespecification.Thisspecificationcoversthewholeprocessofmedicaldeviceclinicaltrials,includingdesignofclinicaltrials,theimplementationof,monitoring,verification,inspection,anddataacquisition,record,andanalyzethesummarizingandreporting.

Thethirdsectionofthisspecificationreferredtointheclinicaltrialofmedicalapparatusandinstruments,referstointheaccreditationofmedicalinstrumentclinicaltrialinstitution,intendstoapplyfortheregistrationofmedicaldeviceinthenormalconditionsofuseissafeandeffectiveforconfirmationorverificationprocess.

Fourthclinicaltrialsofmedicaldevicesshallcomplywiththeprinciplesoflaw,ethicalprinciplesandscientificprinciples.

Article5atorabovetheprovinciallevelfoodanddrugsupervisionandmanagementdepartmentsresponsibleforthesupervisionandmanagementofmedicaldeviceclinicaltrials.Healthandfamilyhealthdepartmentincharge,withinitsscopeoffunctionsandduties,strengthentheclinicaltrialofmedicalapparatusandinstrumentsmanagement.Foodanddrugsupervisionandmanagementdepartments,healthandfamilyhealthdepartmentsshouldestablishthemedicalqualityofclinicaltrialmanagementinformationreportingmechanism,strengthentheclassIIImedicaldevices,includedinthenationalconfigurationoflargemedicalequipmentqualitymanagementobjectiveofmedicalapparatusandinstrumentstocarryoutexaminationandapprovalofclinicaltrialsandthecorrespondingclinicaltrialsupervisionandmanagementofdatacommunications.

Thesecondchapteristhepreparationbeforeclinicaltrial

Article6theclinicaltrialofmedicalapparatusandinstrumentsshallhavesufficientscientificbasisandtheclearpurposeofthetest,andweighonexpectedandthepublichealthbenefitandrisk,expectedbenefitshouldexceedthepossibledamage.

Article7beforeclinicaltrials,thesponsorshalltestdoneinpreclinicalstudiesofmedicalapparatusandinstruments,includingproductdesign(structure,workingprincipleandmechanismofaction,isexpectedtouseandscopeofapplication,theapplicabletechnicalrequirementsandqualityinspection,animaltestingandriskanalysisandresultsshouldbeabletosupporttheclinicaltrial.Qualityinspectionresultsincludingselfinspectionreportandaqualifiedinspectionagencyissuedayearwithintheproductregistrationinspectionreport.

Priortotheeighthclinicaltrials,theapplicantshouldprepareadequatetestingofmedicalequipment.Thedevelopmentofthetestwithmedicalequipmentshallmeettheapplicablerequirementsofthemedicaldevicequalitymanagementsystem.

Thenineclinicaltrialsofmedicaldevicesshallbeintwoormorethantwomedicaldeviceclinicaltrialinstitution.Selectedtestinginstitutionsshallbewithoutqualificationaccreditationofmedicalinstrumentclinicaltrialinstitution,andfacilitiesandconditionsshallmeetthesafetyeffectivelyclinicaltrialexperience.Researchersshouldbeabletobeartheclinicaltrialsofspecialty,qualificationandabilityandtrained.QualificationofmedicalinstrumentclinicaltrialinstitutionidentifiedmanagementmeasuresshallbeformulatedseparatelybytheStateFoodanddrugadministrationshall,jointlywiththeMinistryofhealthandFamilyPlanningCommission.

Article10beforeclinicaltrials,thesponsorandclinicaltrialinstitutionsandresearchersshouldtestdesign,testqualitycontrol,testthedivisionofresponsibilities,sponsortobearthecostsassociatedwiththeclinicaltrialandtestinmayoccurdamagedealingwithprinciplestoreachawrittenagreement.

Article11clinicaltrialsshouldobtainconsentoftheclinicaltrialofmedicalapparatusandinstrumentsinstitutionalethicscommittee.IncludedintheneedforclinicaltrialsandapprovalofclassIIImedicaldevicesdirectory,shouldalsobeapprovedbytheStateFoodanddrugadministration.

Article12priortoclinicaltrials,thesponsorshallbetothelocationofprovinces,autonomousregions,municipalfoodanddrugsupervisionandmanagementdepartmentsfortherecord.Acceptfilingoffoodanddrugsupervisionandadministrationdepartmentshallrecordthesituationinformedclinicaltrialinstitutionislocatedatthesameleveloffoodanddrugsupervisionandmanagementdepartments,aswellashealthandfamilyhealthdepartments.

Thethirdchapteristheprotectionoftherightsandinterestsofthesubjects

ThirteenthclinicaltrialsofmedicaldevicesshallcomplywiththeethicalstandardssetbytheHelsinkideclarationoftheworldmedicalassembly.

Thefourteenthethicalreviewandinformedconsentarethemainmeasurestoprotecttherightsandinterestsofthesubjects.Thepartiesinvolvedinclinicaltrialsshouldassumethecorrespondingethicalresponsibilitiesaccordingtotheirrespectiveresponsibilities.

Article15thesponsorshouldavoidundueinfluenceormisleadingtosubjects,clinicaltrialsandresearchandclinicaltrialparticipantsorrelatedparty.Clinicaltrialinstitutionsandresearchersshouldavoidundueinfluenceormisleadingtosubjects,thesponsorandotherparticipantsinclinicaltrialsorinterestedparties.

Sixteenthapplicants,clinicaltrialsandresearchersshouldnotexaggeratethecompensationmeasuresinvolvedinclinicaltrials,tomisleadtheparticipantstoparticipateinclinicaltrials.

Seventeenthpreclinicaltrials,theapplicantshallsubmitthefollowingdocumentstotheethicscommitteebyresearchersandclinicaltrialinstitutionofmedicalinstrumentclinicaltrialmanagement:

(a)clinicaltrialprogram;(two)researchersmanual;(three)writteninformedconsentdocumentandanyotheravailabletoparticipants(;four)recruitingsubjectsandproceduraldocumentstoitspropaganda;(five)thecasereportformtext;(six)selfinspectionreportandproductregistrationinspectionreport;(seven)researchersresume,professionalexpertise,skills,trainingandotherdocumentstoprovetheirqualifications;(eight)clinicaltrialinstitutionthefacilitiesandconditionstomeetthetestreview;(nine)withthedevelopmentofmedicaldevicesinaccordancewiththerelevantrequirementsofmedicalqualitymanagementsystemfortheteststatement;(ten)otherdocumentsrelatedtoethicalreview.Ethicscommitteeshallupholdtheprinciplesofethicsandscience,reviewandsupervisetheimplementationofclinicaltrials.

Eighteenthoneofthefollowingcircumstancesoccurinthecourseofclinicaltrials,researchersshouldreporttotheclinicaltrialinstitutionofmedicalinstrumentclinicaltrialmanagementdepartment,andthetimelynotificationoftheapplicant,theethicscommitteereport:

(a)seriousadverseevents;(two)progressreport,includingasummaryofsafetyanddeviationreports;(three)foranyamendmenthasbeenapprovedbytheethicscommitteeofthefile,doesnotaffecttherightsandinterestsofthesubjects,safetyandhealth,nonsubstantivechangeswithoutpriorreportsorclinicaltrialswiththepurposeorendnotrelated,butafterwardsshallnotifyinwriting;(four)tosuspend,terminateorsuspendtherequestaftertherecoveryofclinicaltrials(five;)affecttherightsandinterestsofthesubjects,fromclinicaltrialsorclinicaltrialsafetyandhealthscience,includingthedeviationofrequestandreportthedeviation.FortheprotectionofsubjectsWhereaperson'srights,securityandhealtharenotimmediatelyreportedinanemergency,itshallbereportedinwrittenformassoonaspossibleinaccordancewiththerelevantprovisions.

Article19intheprocessofclinicaltrials,asamendedclinicaltrialprotocolsandinformedconsentdocuments,requestdeviation,resumeapausedclinicaltrialsshouldbecancontinuetoimplementuntilitobtainthewrittenapprovaloftheethicscommittee.

Itisgoodtothehealtharticle20shouldbeavoidedasfaraspossibleselectionofminors,pregnantwomen,elderly,personswithmentalobstacleinlifecriticalpatientsassubjects,thatreallyneedtobeselected,itshallabidebytheethicscommitteeoftheadditionalrequirement.Inclinicaltrialsfortheirhealthisspeciallydesigned,andshouldbe.

article20shouldbeavoidedasfaraspossibleselectionofminors,pregnantwomen,elderly,personswithmentalobstacleinlifecriticalpatientsassubjects,thatreallyneedtobeselected,itshallabidebytheethicscommitteeoftheadditionalrequirement.Inclinicaltrialsfortheirhealthisspeciallydesigned,andshouldbe.

Article21insubjectsinclinicaltrials,researchersshouldfullytosubjectsornocapacityforcivil

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 医药卫生 > 基础医学

copyright@ 2008-2023 冰点文库 网站版权所有

经营许可证编号:鄂ICP备19020893号-2